Stay updated on Comparing Bictegravir Combo vs Abacavir Combo in HIV-1 Adult Clinical Trial
Sign up to get notified when there's something new on the Comparing Bictegravir Combo vs Abacavir Combo in HIV-1 Adult Clinical Trial page.

Latest updates to the Comparing Bictegravir Combo vs Abacavir Combo in HIV-1 Adult Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a technical site release rather than a change to the clinical study content.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision label updated to v3.5.0; the previous label v3.4.3 has been removed.SummaryDifference0.0%

- Check61 days agoChange DetectedFooter now displays Revision: v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision: v3.4.2 was added and a generic funding-status notice was removed; these are administrative site updates that do not affect the study content, eligibility criteria, outcomes, or other key details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check97 days agoChange DetectedAdded a government-funding status notice with links to cc.nih.gov and opm.gov, and updated the site revision to v3.4.1 from v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Comparing Bictegravir Combo vs Abacavir Combo in HIV-1 Adult Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Bictegravir Combo vs Abacavir Combo in HIV-1 Adult Clinical Trial page.